Ligation of membrane immunoglobulin leads to inactivation of the signal-transducing ability of membrane immunoglobulin, CD19, CD21, and B-cell gp95.
We have examined the ability of membrane immunoglobulin-binding ligands to desensitize several human B-cell surface molecules that normally transduce signals leading to Ca2+ mobilization. Ligation of membrane IgM or IgD leads to heterologous desensitization of the reciprocal receptor in Epstein-Barr virus-transformed B-cell lines and peripheral blood B cells, as evidenced by a failure of cells to mobilize in response to receptor ligation. Under these conditions CD19, CD21, and B-cell gp95 ligation also did not lead to normal Ca2+ mobilization, indicating that these transducers are also desensitized. The desensitization does not reflect receptor modulation from the cell surface or reduced accessibility to ligand and is long lived, lasting greater than 16 hr. Finally, data that indicate that desensitized cells remain responsive to the G protein activating agent AIF4-, as measured by Ca2+ mobilization, suggest that desensitization reflects uncoupling of these receptors from G proteins that are intermediaries in their transduction of signals. We hypothesize that the molecular target of desensitization may be a recently described membrane immunoglobulin-associated and inducibly tyrosine-phosphorylated protein complex that may function as a master transducer in B cells, analogous to CD3 in T cells.
Department of Immunology, University Hospital for Children and Youth Het Wilhelmina Kinderziekenhuis, Utrecht, The Netherlands.
G T
GT
Rijkers
A W
AW
Griffioen
B J
BJ
Zegers
J C
JC
Cambier
D000535:Aluminum / Q000494:pharmacology; D017607:Aluminum Compounds; D015703:Antigens, CD / Q000502:physiology*; D018941:Antigens, CD19; D000944:Antigens, Differentiation, B-Lymphocyte / Q000502:physiology*; D000954:Antigens, Surface / Q000502:physiology; D001402:B-Lymphocytes / Q000502:physiology*; D002118:Calcium / Q000502:physiology; D004306:Dose-Response Relationship, Immunologic; D005434:Flow Cytometry; D005459:Fluorides / Q000494:pharmacology; D006801:Humans; D007138:Immunoglobulin delta-Chains / Q000502:physiology; D007148:Immunoglobulin mu-Chains / Q000502:physiology; D066298:In Vitro Techniques; D008562:Membrane Glycoproteins / Q000502:physiology*; D011947:Receptors, Antigen, B-Cell / Q000502:physiology*; D011951:Receptors, Complement / Q000502:physiology*; D017464:Receptors, Complement 3d; D011971:Receptors, Immunologic / Q000502:physiology; D015398:Signal Transduction
D017607:Aluminum Compounds; D015703:Antigens, CD; D018941:Antigens, CD19; D000944:Antigens, Differentiation, B-Lymphocyte; D000954:Antigens, Surface; D007138:Immunoglobulin delta-Chains; D007148:Immunoglobulin mu-Chains; D008562:Membrane Glycoproteins; D011947:Receptors, Antigen, B-Cell; D011951:Receptors, Complement; D017464:Receptors, Complement 3d; D011971:Receptors, Immunologic; D000535:Aluminum; D005459:Fluorides; D002118:Calcium; C032311:aluminum fluoride